A
$ Value
$0
Shares
96,000
Price
$0
Filed
Jan 26
Insider
Name
Goeltz II Robert C.
Title
Chief Financial Officer
CIK
0001653881
Roles
Officer
Transaction Details
Transaction Date
2026-01-23
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
96,000
Footnotes
Represents the grant of restricted stock units that vest in four equal annual installments beginning December 15, 2026, subject to the Reporting Person's continued service to the Company. | Includes the unvested portion of the Reporting Person's RSU grants. | The option becomes exercisable in 48 equal monthly installments after January 1, 2026, subject to the Reporting Person's continued service to the Company.
Filing Info
Goeltz II Robert C.'s History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-01-23 | RCUS | A | $0 |
| 2026-01-23 | RCUS | A | $0 |
| 2025-12-31 | RCUS | ▼ | $153K |
| 2025-12-17 | RCUS | ▼ | $132K |
| 2025-12-16 | RCUS | ▼ | $147K |
| 2025-11-26 | RCUS | ▼ | $125K |
| 2025-10-28 | RCUS | ▼ | $100K |
Other Insiders at RCUS (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
ROSEN TERRY J
Chief Executive Officer
|
— | — | 2026-01-23 |
|
Jaen Juan C.
President
|
— | — | 2026-01-23 |
|
Goeltz II Robert C.
Chief Financial Officer
|
— | — | 2026-01-23 |
|
Jarrett Jennifer
Chief Operating Officer
|
— | — | 2026-01-23 |
|
Azoy Alexander
Chief Accounting Officer
|
— | — | 2026-01-23 |
|
Tang Carolyn C.
General Counsel
|
— | — | 2026-01-23 |
|
Markus Richard
Chief Medical Officer
|
— | — | 2026-01-23 |